Holen Sie sich die Stockscreener-App
156.56
3.13%
-5.06
Schlusskurs vom Vortag:
$161.62
Offen:
$160.31
24-Stunden-Volumen:
1.00M
Relative Volume:
1.88
Marktkapitalisierung:
$5.04B
Einnahmen:
$560.03M
Nettoeinkommen (Verlust:
$-150.66M
KGV:
-32.21
EPS:
-4.86
Netto-Cashflow:
$-87.43M
1W Leistung:
-5.46%
1M Leistung:
-11.35%
6M Leistung:
+16.68%
1J Leistung:
+40.61%
1-Tages-Spanne:
$153.05
$162.07
1-Wochen-Bereich:
$153.05
$166.99
52-Wochen-Spanne:
$92.52
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Holdings Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Vergleichen Sie IRTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
156.56 | 5.21B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-09-23 | Eingeleitet | Evercore ISI | In-line |
| 2025-08-20 | Eingeleitet | BofA Securities | Buy |
| 2025-05-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Holdings Inc Aktie (IRTC) Neueste Nachrichten
IRhythm Holdings (NASDAQ:IRTC) Shareholders Are Still up 68% Over 3 Years Despite Pulling Back 3.3% in the Past Week - 富途牛牛
iRhythm Holdings Inc (IRTC) Shares Down 3.76% on Jan 27 - GuruFocus
iRhythm Technologies (NASDAQ:IRTC) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
iRhythm Technologies (NASDAQ:IRTC) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm - marketscreener.com
Patient Monitoring Stocks Q3 Earnings: iRhythm (NASDAQ:IRTC) Best of the Bunch - Finviz
iRhythm Technologies $IRTC Shares Sold by Stephens Investment Management Group LLC - MarketBeat
iRhythm Holdings Inc (IRTC) Shares Up 4.41% on Jan 15 - GuruFocus
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights - marketscreener.com
Inogen (NASDAQ:INGN shareholders incur further losses as stock declines 11% this week, taking five-year losses to 86% - simplywall.st
Is It Time To Rethink iRhythm Holdings (IRTC) After The Recent Share Price Pullback - Yahoo Finance
iRhythm Tech's Stock Selloff Went Too Far After Preliminary Update: Analyst - Benzinga
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Charles River Labs (CRL) and Butterfly Network (BFLY) - The Globe and Mail
SG Americas Securities LLC Trims Stock Position in iRhythm Technologies $IRTC - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Sees Strong Trading Volume Following Analyst Upgrade - Defense World
iRhythm Technologies (IRTC) Expects 2025 Revenue to Exceed $740 Million, 2026 Revenue of $870 Million - Intellectia AI
Aug Volume: Is NeoGenomics Inc stock undervalued right nowQuarterly Profit Summary & Fast Gain Stock Trading Tips - baoquankhu1.vn
iRhythm (IRTC) stock slides as 2026 outlook and holding-company switch land - TechStock²
iRhythm Technologies (NASDAQ:IRTC) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Intel, Salesforce among market cap stock movers on Tuesday - Investing.com
Earnings Miss: Is iRhythm Technologies Inc stock attractive for income investors2025 Fundamental Recap & Weekly Return Optimization Alerts - Bộ Nội Vụ
Oversold Conditions For iRhythm Holdings (IRTC) - Nasdaq
Wells Fargo & Company Forecasts Strong Price Appreciation for iRhythm Technologies (NASDAQ:IRTC) Stock - MarketBeat
Wells Fargo Raises Price Target for iRhythm Technologies (IRTC) - GuruFocus
RSI Check: Will iRhythm Technologies Inc. stock benefit from infrastructure spendingEarnings Performance Report & Weekly Watchlist for Consistent Profits - moha.gov.vn
iRhythm Technologies (IRTC) Is Down 8.6% After Surpassing 2025 Guidance And Turning Free Cash Flow Positive - Sahm
iRhythm Technologies forecasts 17-18% revenue growth for 2026 By Investing.com - Investing.com Nigeria
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), SI-Bone (SIBN) and Guardant Health (GH) - The Globe and Mail
iRhythm (IRTC) stock drops after JPM update points to $880 million 2026 revenue - TechStock²
Irhythm Technologies, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
IRhythm Technologies, Inc. Updates Earnings Guidance for the Full Year 2025 - marketscreener.com
iRhythm Technologies: Best in Business 2025 - Modern Healthcare
IRTC: Strong growth, profitability, and AI-driven expansion position the business for continued leadership - TradingView — Track All Markets
iRhythm Technologies stock maintains Overweight rating at Morgan Stanley By Investing.com - Investing.com Canada
Owlet Stock Up More Than 82% in the Past 6 Months: Still Worth Buying? - Finviz
iRhythm Technologies (NASDAQ:IRTC) Receives Buy Rating from Needham & Company LLC - MarketBeat
Needham Reiterates Buy Rating on iRhythm Technologies (IRTC) at $244 | IRTC Stock News - GuruFocus
IRhythm Technologies Provides 2026 Revenue Guidance - marketscreener.com
iRhythm Technologies Reports Strong Preliminary Q4 2025 Results and 2026 Revenue Guidance at J.P. Morgan Healthcare Conference - Quiver Quantitative
iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference - The Globe and Mail
(IRTC) iRhythm Technologies Expects 2026 Revenue Range $870M to $880M, vs. FactSet Est of $863.6M - marketscreener.com
IRhythm Technologies Inc anticipate FY25 revenue to exceed high end of previously stated guidance range of $740 million provided in October 2025 - marketscreener.com
iRhythm Technologies Inc Anticipate Fy25 Revenue To Exceed High End Of Previously Stated Guidance Range Of $740 Million Provided In October 2025 - TradingView — Track All Markets
iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business ... - Bluefield Daily Telegraph
iRhythm Technologies, Inc. Shares Preliminary Fourth - GlobeNewswire
IRhythm Technologies, Inc. (IRTC) Stock Analysis: A 22.76% Upside Potential Beckons Investors - DirectorsTalk Interviews
Trading Systems Reacting to (IRTC) Volatility - Stock Traders Daily
How sustainable is iRhythm Technologies Inc. stock dividend payoutForecast Cut & Long-Term Growth Portfolio Plans - Улправда
iRhythm Technologies (NASDAQ:IRTC) Shares Down 4.8%What's Next? - MarketBeat
Why iRhythm stock is sliding today as Wall Street looks to JPM Healthcare Conference - TechStock²
Finanzdaten der Irhythm Holdings Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):